254 related articles for article (PubMed ID: 12091793)
1. [PAI-1, the primary plasmatic inhibitor of fibrinolysis. Physiopathologic role and molecular mechanisms].
Banfi C; Mussoni L; Tremoli E
Minerva Endocrinol; 2002 Sep; 27(3):181-91. PubMed ID: 12091793
[TBL] [Abstract][Full Text] [Related]
2. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.
Juhan-Vague I; Alessi MC; Morange PE
Ann Med; 2000 Dec; 32 Suppl 1():78-84. PubMed ID: 11209987
[TBL] [Abstract][Full Text] [Related]
3. Fat cell function and fibrinolysis.
Alessi MC; Morange P; Juhan-Vague I
Horm Metab Res; 2000; 32(11-12):504-8. PubMed ID: 11246816
[TBL] [Abstract][Full Text] [Related]
4. Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases.
Mavri A; Alessi MC; Juhan-Vague I
J Intern Med; 2004 Apr; 255(4):448-56. PubMed ID: 15049879
[TBL] [Abstract][Full Text] [Related]
5. PAI-1, obesity, insulin resistance and risk of cardiovascular events.
Juhan-Vague I; Alessi MC
Thromb Haemost; 1997 Jul; 78(1):656-60. PubMed ID: 9198234
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance.
Alessi MC; Poggi M; Juhan-Vague I
Curr Opin Lipidol; 2007 Jun; 18(3):240-5. PubMed ID: 17495595
[TBL] [Abstract][Full Text] [Related]
7. Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: lessons from the liver.
Dimova EY; Kietzmann T
Thromb Haemost; 2008 Dec; 100(6):992-1006. PubMed ID: 19132222
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease.
De Taeye B; Smith LH; Vaughan DE
Curr Opin Pharmacol; 2005 Apr; 5(2):149-54. PubMed ID: 15780823
[TBL] [Abstract][Full Text] [Related]
9. Visceral fat as a determinant of fibrinolysis and hemostasis.
Mertens I; Van Gaal LF
Semin Vasc Med; 2005 Feb; 5(1):48-55. PubMed ID: 15968580
[TBL] [Abstract][Full Text] [Related]
10. Contribution of PAI-1 in cardiovascular pathology.
Alessi MC; Juhan-Vague I
Arch Mal Coeur Vaiss; 2004 Jun; 97(6):673-8. PubMed ID: 15283042
[TBL] [Abstract][Full Text] [Related]
11. Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1.
Sato Y; Dong J; Imagawa S; Ishimori N; Furumoto T; Tsutsui H; Sobel BE; Fujii S
Coron Artery Dis; 2008 Aug; 19(5):355-61. PubMed ID: 18607173
[TBL] [Abstract][Full Text] [Related]
12. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.
Skurk T; Hauner H
Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1357-64. PubMed ID: 15356668
[TBL] [Abstract][Full Text] [Related]
13. Hypofibrinolysis and insulin-resistance.
Juhan-Vague I; Vague P
Diabete Metab; 1991 May; 17(1 Pt 2):96-100. PubMed ID: 1936490
[TBL] [Abstract][Full Text] [Related]
14. Food deprivation induces adipose plasminogen activator inhibitor-1 (PAI-1) expression without accumulation of plasma PAI-1 in genetically obese and diabetic db/db mice.
Oishi K; Ohkura N; Matsuda J; Ishida N
Thromb Haemost; 2007 Oct; 98(4):864-70. PubMed ID: 17938813
[TBL] [Abstract][Full Text] [Related]
15. Update on plasminogen activator inhibitor-1.
Vaughan D
Can J Cardiol; 1998 Jul; 14 Suppl D():14D-15D. PubMed ID: 9713421
[TBL] [Abstract][Full Text] [Related]
16. [Progress in knowledge about fibrinolysis regulation].
Cierniewski CS
Acta Haematol Pol; 1994; 25(2 Suppl 2):15-26. PubMed ID: 7998470
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B
Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
[TBL] [Abstract][Full Text] [Related]
18. De novo synthesis of diacylglycerol in endothelium may mediate the association between PAI-1 and the insulin resistance syndrome.
McCarty MF
Med Hypotheses; 2005; 64(2):388-93. PubMed ID: 15607575
[TBL] [Abstract][Full Text] [Related]
19. Stimulation in vivo of expression of intra-abdominal adipose tissue plasminogen activator inhibitor Type I by proinsulin.
Nordt TK; Bode C; Sobel BE
Diabetologia; 2001 Sep; 44(9):1121-4. PubMed ID: 11596666
[TBL] [Abstract][Full Text] [Related]
20. [From fibrinogen to fibrin and its dissolution].
Juhan-Vague I; Hans M
Bull Acad Natl Med; 2003; 187(1):69-82; discussion 83-4. PubMed ID: 14556455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
